Browse EX-10 agreements

MASTER SURFACE USE AGREEMENT

This Master Surface Use Agreement (this “Agreement”) is made and entered into this 1st day of July 2026 (the “Effective Date”), by and between **US Land Guild, LLC, **whose address is 1751 River Run, Suite 405, Fort Worth, TX 76107, (“Surface Owner”) and **Blackbeard Operating, LLC, **whose address is 300 N. Loraine, Suite 300, Midland, Texas 79701 (“Operator”). Together Operator and Surface Owner will hereinafter be referred to at times as the “Parties”.

**WHEREAS, **reference is hereby made to the following described lands (the “Lands):

See Exhibit “A”

**WHEREAS, **Surface Owner is the owner of the surface estate in and to the Lands; and,

**WHEREAS, **Operator is the owner and holder of certain oil and gas leases and/or may become the owner of oil and gas leases and/or other mineral interests within the Lands;

…

MASTER SERVICES AGREEMENT

BY AND BETWEEN

PBT LAND AND MINERALS, INC.,

AS COMPANY,

AND

BLACKBEARD OPERATING, LLC,

AS SERVICE PROVIDER

TABLE OF CONTENTS

** **

		Page
Article I DEFINITIONS		1

…

[Schedules and similar attachments to this exhibit have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant agrees to furnish supplementally a copy of any omitted schedule or attachment to the Securities and Exchange Commission upon request.]

Separation and Settlement Agreement

This Separation and Settlement Agreement (this “Agreement”) is entered into by TruGolf Holdings, Inc., a Nevada corporation (the “Company”), and Christopher Jones (“Jones”). Each is a “Party,” and together they are the “Parties.” TruGolf, Inc. (the “Operating Company”), TruGolf Links Franchising, LLC (the “Franchise Company”), and Christopher Jones and Audree Jones, solely as the duly authorized trustees of The Audree Redd Jones Trust (the “Trust”), join for the limited purposes stated in Section 1(e). The Company, Jones and those joining in those capacities are the “Signatories.”

	1.	Definitions and Effectiveness

…

Execution Version

***MASTER CREDIT AGREEMENT ***

THIS MASTER CREDIT AGREEMENT (this “Agreement”) is entered into as of September 23, 2026, by and among GROUP 1 REALTY, INC., a corporation organized under the laws of the State of Delaware (“G1 Realty” or “Borrower”), and BANK OF AMERICA, N.A., a national banking association (“Bank”).

The effective date of this Agreement shall be the date that Bank has received this Agreement and other documents required by Bank in connection herewith, all in form and substance satisfactory to Bank and duly executed by all parties.

**RECITALS **

Borrower has requested that Bank extend and/or continue credit to Borrower as described below, and Bank has agreed to provide such credit to Borrower on the terms and conditions contained herein.

NOW, THEREFORE, for valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Bank and Borrower hereby agree as follows:

**ARTICLE I **

**CREDIT TERMS **

…

**THE EXCHANGE CONTEMPLATED HEREIN IS INTENDED TO COMPORT WITH THE REQUIREMENTS OF SECTION 3(a)(9) OF THE SECURITIES ACT OF 1933, AS AMENDED. **

***EXCHANGE AGREEMENT ***

This Exchange Agreement (this “Agreement”) is entered into as of September 23, 2026 (the “Effective Date”) by and between Streeterville Capital, LLC, a Utah limited liablity company (“Lender”), and Jaguar Health, Inc., a Delaware corporation (“Borrower”). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Original Note (as defined below).

A. Company previously sold and issued to Investor that certain Secured Promissory Note dated November 12, 2025 (the “Original Note”) pursuant to that certain Note Purchase Agreement dated November 12, 2025 (the “Purchase Agreement,” and together with the Original Note and all other documents entered into in conjunction therewith, the “Transaction Documents”).

…

Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. In addition, certain personally identifiable information has been redacted from this exhibit. Redacted information is indicated by [***].

** **

FRAMEWORK PURCHASE AGREEMENT

* *

concluded pursuant to § 409 et seq. of Act no. 513/1991 Coll. Commercial Code as amended

* *

PARTIES:

** **

…

***FORWARD PURCHASE AGREEMENT ***

This Forward Purchase Agreement (this “Agreement”) is entered into as of    , 2026, by and between Fraizer Life Sciences Acquisition Corp. II, an exempted company with limited liability under the laws of the Cayman Islands (the “Company”), and Frazier Life Sciences Public Fund, L.P., a Delaware limited partnership (the “Purchaser”).

WHEREAS, the Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”);

WHEREAS, the Company has filed with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on Form S-1 (the “Registration Statement”) for its initial public offering (“IPO”) of 7,500,000 Class A ordinary shares, par value $0.0001 per share (the “Class*** A Shares*”, and the Class A Shares sold in the IPO, the “Public Shares”) at a price of $10.00 per Public Share;

…

, 2026

Frazier Life Sciences Acquisition Corp. II

1001 Page Mill Road

Building 4, Suite 200B

Palo Alto, California 93404

Re:	Initial Public Offering

Ladies and Gentlemen:

This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Frazier Life Sciences Acquisition Corp. II, a Cayman Islands exempted company (the “Company”), and Jefferies LLC, as representative (the “Representative”) of the several underwriters (each, an “Underwriter” and collectively, the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”), of up to 7,500,000 of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Class********* A Ordinary Shares***”). The Class A Ordinary Shares will be sold in the Public Offering pursuant to a registration statement on Form S-1 and prospectus (the “Prospectus”) filed by the Co

…

**FORM OF INDEMNITY AGREEMENT **

THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of [ ], 2026, by and between Frazier Life Sciences Acquisition Corp. II, a Cayman Islands exempted company (the “Company”), and the undersigned (“Indemnitee”).

**RECITALS **

WHEREAS, highly competent persons have become more reluctant to serve publicly-held companies as directors, officers or in other capacities unless they are provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of such companies;

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that, in order to attract and retain qualified individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its Subsidiaries (as defined below) from certain liabilities;

…

**Frazier Life Sciences Acquisition Corp. II **

August 12, 2026

Frazier Life Sciences Holdings II LLC

RE:	*Securities Subscription Agreement *

Gentlemen:

This agreement (this “Agreement”) is entered into on August 12, 2026 by and between Frazier Life Sciences Holdings II LLC, a Cayman Islands limited liability company (the “Subscriber” or “you”), and Frazier Life Sciences Acquisition Corp. II, a Cayman Islands exempted company (the “Company”). Pursuant to the terms hereof, the Company hereby accepts the offer the Subscriber has made to subscribe for and purchase 2,156,250 Class B ordinary shares, $0.0001 par value per share (the “Shares”), up to 281,250 of which are subject to forfeiture by you if the underwriters of the initial public offering (“IPO”) of Class A ordinary shares, $0.0001 par value per share, of the Company do not fully exercise their over-allotment option (the “Over-allotment Option”). The Company’s and the Subscriber’s agreements regar

…

**REGISTRATION RIGHTS AGREEMENT **

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of    , 2026, is made and entered into by and among Frazier Life Sciences Acquisition Corp. II, a Cayman Islands exempted company (the “Company”), Frazier Life Sciences Holdings II, LLC, a Cayman Islands limited liability company (the “Sponsor”), and each of the undersigned parties listed on the signature page hereto under “Holders” (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to Section*** 5.2* of this Agreement, a “Holder” and collectively the “Holders”).

**RECITALS **

WHEREAS, the Company has 1,875,000 Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”), issued and outstanding;

…

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

**PROMISSORY NOTE **

Principal Amount: up to $300,000		Dated as of August 12, 2026

(as set forth on the Schedule of Borrowings attached hereto)

…